Advertisement

Topics

Intellipharmaceutics International Inc.: Intellipharmaceutics Announces US$3.5 Million Registered Direct Offering

09:08 EDT 14 Mar 2018 | FinanzNachrichten

TORONTO, ON / ACCESSWIRE / March 14, 2018 / Intellipharmaceutics International Inc. (NASDAQ: IPCI) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in th...

Original Article: Intellipharmaceutics International Inc.: Intellipharmaceutics Announces US$3.5 Million Registered Direct Offering

NEXT ARTICLE

More From BioPortfolio on "Intellipharmaceutics International Inc.: Intellipharmaceutics Announces US$3.5 Million Registered Direct Offering"

Advertisement
Quick Search
Advertisement
Advertisement